IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study
about
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activityUrban legends: recurrent aphthous stomatitisA phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinomaLAG-3 in Cancer Immunotherapy.Advances in targeting cell surface signalling molecules for immune modulationThe CD4-like molecule LAG-3, biology and therapeutic applications.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.
P2860
Q21245463-72B9F27D-D170-4BD4-90EE-F8735285CA8BQ24635082-0D4535C5-CE61-44C3-94E0-523A6EC5F515Q30412791-C0309802-B7DB-440B-AC10-E609B7F6BEAEQ36416383-03AC1834-58E3-4214-B917-73434006C141Q36973787-656A935F-9002-4954-8C41-505F74E83BD2Q37818246-BC4C8DCB-E181-4D7E-A956-DCD67067B803Q55174561-253E6AB8-A34B-47FD-ABB9-FAB93BC9B505
P2860
IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@ast
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@en
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@en-gb
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@nl
type
label
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@ast
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@en
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@en-gb
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@nl
prefLabel
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@ast
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@en
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@en-gb
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@nl
P2093
P2860
P356
P1476
IMP321 (sLAG-3), an immunopote ...... mised controlled phase I study
@en
P2093
Caroline Grygar
Chrystelle Brignone
Frédéric Triebel
Gaëlle Perrin
Manon Marcu
P2860
P2888
P356
10.1186/1476-8518-5-5
P407
P577
2007-01-01T00:00:00Z
P5875
P6179
1050149335